ZURA (zurabio.com) Net Profit

ZURA (Zura Bio) - company brandmark

This price chart illustrates the price action of Zura Bio Limited (ZURA), whose profit stands at -0.12. The business relies on forging alliances with biolabs to accelerate the market entry of immune therapies. However, the lack of sales and the probability of failure in phase II trials create risks. High R&D expenditures could lead to new share issuances and the dilution of shareholder equity.

ZURA (Zura Bio) Net Profit history from 04/28/2023 to 10/31/2026

Analytical breakdowns and data insights for company Zura Bio (ZURA)

- price and consensus price forecast:
Stock Quotes zurabio.com|ZURA - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Zura Bio|ZURA - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Zura Bio|ZURA - Book Capitalization|Market Capitalization to Book Value zurabio.com|ZURA - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Zura Bio Limited|ZURA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Zura Bio Ltd|ZURA - Company Total Debt|Debts to Book Capitalization Zura Bio|ZURA - Company Long-Term Debt|Company Short-Term Indebtedness Zura Bio|Immediate Liquidity zurabio.com
- net income and valuation multiples indicators:
ZURA - Net Income
Summary company analysis:Zura Bio Limited
Core merchandise of Zura Bio Limited

To minimize investment risks, Zura Bio Limited (ZURA) requires monitoring of operational efficiency. This metric aggregates the market consensus of traders, reflecting the issuer's actual daily financial result. Analyzing the company's net income allows for the identification of hidden threats or the asset's growth potential. The stability of this indicator confirms the effectiveness of raw material flow diversification. The seamless logistics of clinical drugs converts directly into profit sustainability.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|PGEN: Net Income|Profit After Tax PHAR|NKTR (Nektar Therapeutics) - Net Income|upstreambio.com (UPB) - Net Profit|Company Net Income Zenas Biopharma|IMNM: Final Profit|Net Profit GOSS|Net Profit KalVista Corp (KALV)|Septerna Inc - Net Income|Final Profit PVLA|Savara - Net Profit|RIGL: Company Net Income|ANAB: Net Profit|ATXS - Net Financial Result|Company Net Income enGene Holdings Inc.|Company Net Income rapt.com RAPT|Net Income JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris Therapeutics Inc.) - Final Profit|Company Net Income Kyverna KYTX|Tiziana Life Sciences, Ltd. - Company Net Income|Cabaletta Bio, Inc. - Net Profit|Net Financial Result ventyxbio.com VTYX|Theratechnologies (THTX) - Company Net Income|Net Income Avalo Therapeutics, Inc.|ELDN (Eledon) - Net Profit|Agenus, Inc (AGEN) - Net Financial Result|Net Income CLYM (Climb Bio Inc)|Profit After Payment of Taxes ATYR|Net Profit ADAG (Adagene Inc.)|ImageneBio (IMA) - Company Net Income|Shattuck Therapeutics - Net Profit|EQ (Equillium, Inc.) - Company Profit|CNTB (connectbiopharm.com) - Net Income|Profit After Tax IMUX (Immunic)|Net Income ATRA|Net Profit InflaRx GmbH|Company Net Income X4 Pharma (XFOR)|ACET (adicetbio.com) - Final Profit|Net Profit CELU (Celularity)|Net Profit inmunebio.com INMB|BRNS - Company Net Income|Profit After Tax KZR|SABS: Net Profit|Akari Therapeutics, Plc - Final Profit|ENLV (Enlivex Therapeutics Ltd) - Net Profit|Net Profit Q32 Bio Corp|Company Net Income GeoVax (GOVX)|EDSA (Edesa Biotech Inc) - Final Profit|Company Net Income iBio Corp IBIO|CARM - Net Income|XTL Biopharmaceuticals - Net Profit|BOLT - Net Profit|HCWB (hcwbiologics.com) - Net Income|Aptevo Therapeutics Inc. - Final Profit|AIM (AIM ImmunoTech) - Net Profit|Aditxt Corp (ADTX) - Net Financial Result|Company Net Income GRI Bio, Inc. (GRI)|Net Income xortx.com XRTX|Company Net Income Vyome Holdings HIND|REVB - Net Income|INDP: Net Income|SCNI - Net Profit|calcimedica.com (CALI) - Company Net Income|Company Profit AFMD|ALLK (Allakos Inc) - Net Profit|Company Net Income HOOKIPA HOOK|Net Income IGMS (IGM Biosciences, Inc.)|ITOS: Profit After Tax|Ocean Biomedical, Inc. - Net Income|Net Profit tcbiopharm.com TCBP|THRD - Company Net Income